Advertisement

Clinical Significance of Extra-Colonic Manifestations of Familial Adenomatous Polyposis

  • Yehuda Kariv
  • Hagit Tulchinsky
  • Micha Rabau

Keywords

Familial Adenomatous Polyposis Adenomatous Polyposis Coli Desmoid Tumor Restorative Proctocolectomy Duodenal Adenoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Boardman LA (2002) Heritable colorectal cancer syndromes: recognition and preventive management. Gastroenterol Clin North Am 31:1107–1131PubMedCrossRefGoogle Scholar
  2. 2.
    Tonelli F, Nardi F, Bechi P et al (1985) Extracolonic polyps in familial polyposis coli and Gardner’s syndrome. Dis Colon Rectum 28:664–668PubMedCrossRefGoogle Scholar
  3. 3.
    Sarre RG, Frost AG, Jagelman DG et al (1987) Gastric and duodenal polyps in familial adenomatous polyposis: a prospective study of the nature and prevalence of upper gastrointestinal polyps. Gut 28:306–314PubMedGoogle Scholar
  4. 4.
    Bulow S, Bjork J, Christensen IJ et al (2004) Duodenal adenomatosis in familial adenomatous polyposis. Gut 53:381–386PubMedCrossRefGoogle Scholar
  5. 5.
    Heiskanen I, Kellokumpu I, Jarvinen H (1999) Management of duodenal adenomas in 98 patients with familial adenomatous polyposis. Endoscopy 31:412–416PubMedCrossRefGoogle Scholar
  6. 6.
    Brosens LA, Keller JJ, Offerhaus GJ et al (2005) Prevention and management of duodenal polyps in familial polyposis. Gut 54:1034–1043PubMedCrossRefGoogle Scholar
  7. 7.
    Lillemoe K, Imbembo AL (1980) Malignant neoplasms of the duodenum. Surg Gynecol Obstet 150:822–826PubMedGoogle Scholar
  8. 8.
    Pauli RM, Pauli ME, Hall JG (1980) Gardner syndrome and periampullary malignancy. Am J Med Genet 6:205–219PubMedCrossRefGoogle Scholar
  9. 9.
    Offerhaus GJ, Giardiello FM, Krush AJ et al (1992) The risk of upper gastrointestinal cancer in familial adenomatous polyposis. Gastroenterology 102:1980–1982PubMedGoogle Scholar
  10. 10.
    Vasen HF, Bulow S, Myrhoj T et al (1997) Decision analysis in the management of duodenal adenomatosis in familial adenomatous polyposis. Gut 40:716–719PubMedCrossRefGoogle Scholar
  11. 11.
    Bjork J, Akerbrant H, Iselius L et al (2001) Periampullary adenomas and adenocarcinomas in familial adenomatous polyposis: cumulative risks and APC gene mutations. Gastroenterology 121:1127–1135PubMedCrossRefGoogle Scholar
  12. 12.
    Spigelman AD, Williams CB, Talbot IC et al (1989) Upper gastrointestinal cancer in patients with familial adenomatous polyposis. Lancet 2:783–785PubMedCrossRefGoogle Scholar
  13. 13.
    Mahmoud NN, Dannenberg AJ, Bilinski RT et al (1999) Administration of an unconjugated bile acid increases duodenal tumors in a murine model of familial adenomatous polyposis. Carcinogenesis 20:299–303PubMedCrossRefGoogle Scholar
  14. 14.
    Friedl W, Caspari R, Sengteller M et al (2001) Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Experience from 680 FAP families. Gut 48:515–521PubMedCrossRefGoogle Scholar
  15. 15.
    Soravia C, Berk T, Madlensky L et al (1998) Genotypephenotype correlations in attenuated adenomatous polyposis coli. Am J Hum Genet 62:1290–1301PubMedCrossRefGoogle Scholar
  16. 16.
    Saurin JC, Ligneau B, Ponchon T et al (2002) The influence of mutation site and age on the severity of duodenal polyposis in patients with familial adenomatous polyposis. Gastrointest Endosc 55:342–347PubMedCrossRefGoogle Scholar
  17. 17.
    Bertario L, Russo A, Sala P et al (2003) Hereditary colorectal tumor registry: multiple approach to the exploration of genotype-phenotype correlations in familial adenomatous polyposis. J Clin Oncol 21:1698–1707PubMedCrossRefGoogle Scholar
  18. 18.
    Groves C, Lamlum H, Crabtree M et al (2002) Mutation cluster region, association between germ-line and somatic mutations and genotype-phenotype correlation in upper gastrointestinal familial adenomatous polyposis. Am J Pathol 160:2055–2061PubMedGoogle Scholar
  19. 19.
    Matsumoto T, Iida M, Kobori Y et al (2002) Progressive duodenal adenomatosis in a familial adenomatous polyposis pedigree with APC mutation at codon 1556. Dis Colon Rectum 45:229–233PubMedCrossRefGoogle Scholar
  20. 20.
    Leggett BA, Young JP, Biden K et al (1997) Severe upper gastrointestinal polyposis associated with sparse colonic polyposis in a familial adenomatous polyposis family with an APC mutation at codon 1520. Gut 41:518–521PubMedCrossRefGoogle Scholar
  21. 21.
    Spigelman AD, Talbot IC, Penna C (1994) Evidence for adenoma-carcinoma sequence in the duodenum of patients with familial adenomatous polyposis: the Leeds Castle Polyposis Group (Upper Gastrointestinal Committee). J Clin Pathol 47:709–710PubMedGoogle Scholar
  22. 22.
    Groves CJ, Saunders BP, Spigelman AD et al (2002) Duodenal cancer in patients with familial adenomatous polyposis (FAP): results of a 10 year prospective study. Gut 50:636–641PubMedCrossRefGoogle Scholar
  23. 23.
    Saurin JC, Gutknecht C, Napoleon B et al (2004) Surveillance of duodenal adenomas in familial adenomatous polyposis reveals high cumulative risk of advanced disease. J Clin Oncol 22:493–498PubMedCrossRefGoogle Scholar
  24. 24.
    Burke CA, Beck GJ, Church JM et al (1999) The natural history of untreated duodenal and ampullary adenomas in patients with familial adenomatous polyposis followed in an endoscopic surveillance program. Gastrointest Endosc 49:358–364PubMedCrossRefGoogle Scholar
  25. 25.
    Moozar KL, Madlensky L, Berk T et al (2002). Slow progression of periampullary neoplasia in familial adenomatous polyposis. J Gastrointest Surg 6:831–837PubMedCrossRefGoogle Scholar
  26. 26.
    Morpurgo E, Vitale GC, Galandiuk S et al (2004) Clinical characteristics of familial adenomatous polyposis and management of duodenal adenomas. J Gastrointest Surg 8:559–564PubMedCrossRefGoogle Scholar
  27. 27.
    Alarcon FJ, Burke CA, Church JM et al (1999) Familial adenomatous polyposis: efficacy of endoscopic and surgical treatment for advanced duodenal adenomas. Dis Colon Rectum 42:1533–1536PubMedCrossRefGoogle Scholar
  28. 28.
    Soravia C, Berk T, Haber G et al (1997) Management of advanced duodenal polyposis in familial adenomatous polyposis. J Gastrointest Surg 1:474–478PubMedCrossRefGoogle Scholar
  29. 29.
    Bertoni G, Sassatelli R, Nigrisoli E et al (1997) Endoscopic snare papillectomy in patients with familial adenomatous polyposis and ampullary adenoma. Endoscopy 29:685–688PubMedGoogle Scholar
  30. 30.
    Penna C, Phillips RK, Tiret E et al (1993) Surgical polypectomy of duodenal adenomas in familial adenomatous polyposis: experience of two European centres. Br J Surg 80:1027–1029PubMedGoogle Scholar
  31. 31.
    Penna C, Bataille N, Balladur P et al (1998) Surgical treatment of severe duodenal polyposis in familial adenomatous polyposis. Br J Surg 85:665–668PubMedCrossRefGoogle Scholar
  32. 32.
    de Vos tot Nederveen Cappel WH, Jarvinen HJ, Bjork J et al (2003) Worldwide survey among polyposis registries of surgical management of severe duodenal adenomatosis in familial adenomatous polyposis. Br J Surg 90:705–710CrossRefGoogle Scholar
  33. 33.
    Ruo L, Coit DG, Brennan MF et al (2002) Long-term follow-up of patients with familial adenomatous polyposis undergoing pancreaticoduodenal surgery. J Gastrointest Surg 6:671–675PubMedCrossRefGoogle Scholar
  34. 34.
    Farnell MB, Sakorafas GH, Sarr MG et al (2000) Villous tumors of the duodenum: reappraisal of local vs. extended resection. J Gastrointest Surg 4:13–21PubMedCrossRefGoogle Scholar
  35. 35.
    Chung RS, Church JM, van Stolk R (1995) Pancreassparing duodenectomy: indications, surgical technique and results. Surgery 117:254–259PubMedCrossRefGoogle Scholar
  36. 36.
    Kalady MF, Clary BM, Tyler DS et al (2002) Pancreaspreserving duodenectomy in the management of duodenal familial adenomatous polyposis. J Gastrointest Surg 6:82–87PubMedCrossRefGoogle Scholar
  37. 37.
    Balladur P, Penna C, Tiret E et al (1993) Pancreaticoduodenectomy for cancer and precancer in familial adenomatous polyposis. Int J Colorectal Dis 8:151–153PubMedCrossRefGoogle Scholar
  38. 38.
    Gallagher MC, Shankar A, Groves CJ et al (2004) Pylorus-preserving pancreaticoduodenectomy for advanced duodenal disease in familial adenomatous polyposis. Br J Surg 91:1157–1164PubMedCrossRefGoogle Scholar
  39. 39.
    Mackey R, Walsh RM, Chung R et al (2005) Pancreassparing duodenectomy is effective management for familial adenomatous polyposis. J Gastrointest Surg 9:1088–1093PubMedCrossRefGoogle Scholar
  40. 40.
    Nugent KP, Farmer KC, Spigelman AD et al (1993) Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis. Br J Surg 80:1618–1619PubMedGoogle Scholar
  41. 41.
    Debinski HS, Trojan J, Nugent KP et al (1995) Effect of sulindac on small polyps in familial adenomatous polyposis. Lancet 345:855–856PubMedCrossRefGoogle Scholar
  42. 42.
    Phillips RK, Wallace MH, Lynch PM et al (2002) A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis. Gut 50:857–860PubMedCrossRefGoogle Scholar
  43. 43.
    Maclean AR, McLeod RS, Berk T et al (2001) A randomized trial comparing ursodeoxycholic acid and rofecoxib, a selective COX-2 inhibitor, in the treatment of advanced duodenal adenomas in patients with familial adenomatous polyposis. Abstract. Gastroenterology 120[Suppl 1]:A–254Google Scholar
  44. 44.
    Sawada T, Muto T (1997) Role of upper gastrointestinal surveillance in patients with familial adenomatous polyposis. Gastrointest Endosc Clin N Am 7:99–111PubMedGoogle Scholar
  45. 45.
    Offerhaus GJ, Entius MM, Giardiello FM (1999) Upper gastrointestinal polyps in familial adenomatous polyposis. Hepatogastroenterology 46:667–669PubMedGoogle Scholar
  46. 46.
    Kadmon M, Tandara A, Herfarth C (2001) Duodenal adenomatosis in familial adenomatous polyposis coli: a review of the literature and results from the Heidelberg Polyposis Register. Int J Colorectal Dis 16:63–75PubMedCrossRefGoogle Scholar
  47. 47.
    Choudhry U, Boyce HW Jr, Coppola D (1998) Proton pump inhibitor-associated gastric polyps: a retrospective analysis of their frequency, and endoscopic, histologic, and ultrastructural characteristics. Am J Clin Pathol 110:615–621PubMedGoogle Scholar
  48. 48.
    Abraham SC, Nobukawa B, Giardiello FM et al (2000) Fundic gland polyps in familial adenomatous polyposis: neoplasms with frequent somatic adenomatous polyposis coli gene alterations. Am J Pathol 157:747–754PubMedGoogle Scholar
  49. 49.
    Sekine S, Shimoda T, Nimura S et al (2004) High-grade dysplasia associated with fundic gland polyposis in a familial adenomatous polyposis patient, with special reference to APC mutation profiles. Mod Pathol 17:1421–1426PubMedCrossRefGoogle Scholar
  50. 50.
    Wallace MH, Phillips RK (1998) Upper gastrointestinal disease in patients with familial adenomatous polyposis. Br J Surg 85:742–750PubMedCrossRefGoogle Scholar
  51. 51.
    Park JG, Park KJ, Ahn YO et al (1992) Risk of gastric cancer among Korean familial adenomatous polyposis patients: report of three cases. Dis Colon Rectum 35:996–998PubMedCrossRefGoogle Scholar
  52. 52.
    Iwama T, Mishima Y, Utsunomiya J (1993) The impact of familial adenomatous polyposis on the tumorigenesis and mortality at the several organs: its rational treatment. Ann Surg 217:101–108PubMedCrossRefGoogle Scholar
  53. 53.
    Polese L, Keighley MR (2003) Adenomas at resection margins do not influence the long-term development of pouch polyps after restorative proctocolectomy for familial adenomatous polyposis. Am J Surg 186:32–34PubMedCrossRefGoogle Scholar
  54. 54.
    Parc Y, Piquard A, Dozois RR et al (2004) Long term outcome of familial adenomatosis polyposis patients after restorative coloproctectomy. Ann Surg 239:378–382PubMedCrossRefGoogle Scholar
  55. 55.
    Thompson-Fawcett MW, Marcus VA, Redston M et al (2001) Adenomatous polyps develop commonly in the ileal pouch of patients with familial adenomatous polyposis. Dis Colon Rectum 44:347–353PubMedCrossRefGoogle Scholar
  56. 56.
    Groves CJ, Beveridge G, Swain DJ et al (2005) Prevalence and morphology of pouch and ileal adenomas in familial adenomatous polyposis. Dis Colon Rectum 48:816–23PubMedCrossRefGoogle Scholar
  57. 57.
    Parc YR, Olschwang S, Desaint B et al (2001) Familial adenomatous polyposis: prevalence of adenomas in the ileal pouch after restorative proctocolectomy. Ann Surg 233:360–364PubMedCrossRefGoogle Scholar
  58. 58.
    Church J (2005) Ileoanal pouch neoplasia in familial adenomatous polyposis: an underestimated threat. Dis Colon Rectum 48:1708–1713PubMedCrossRefGoogle Scholar
  59. 59.
    Quah HM, Samad A, Maw A (2005) Ileostomy carcinomas a review: the latent risk after colectomy for ulcerative colitis and familial adenomatous polyposis. Colorectal Dis 7:538–544PubMedCrossRefGoogle Scholar
  60. 60.
    Burt RW, Berenson MM, Lee RG et al (1984) Upper gastrointestinal polyps in Gardner’s syndrome. Gastroenterology 86(2):295–301PubMedGoogle Scholar
  61. 61.
    Järvinen HJ (1997) Desmoid disease as a part of familial adenomatous polyposis coli. Acta Chir Scand 153:379–383Google Scholar
  62. 62.
    Heiskanen I, Järvinen HJ (1996) Occurrence of desmoid tumours in familial adenomatous polyposis and result of treatment. Int J Colorectal Dis 11: 157–162PubMedCrossRefGoogle Scholar
  63. 63.
    Gurbuz AK, Giardiello FM, Petersen GM et al (1994) Desmoid tumors in familial adenomatous polyposis. Gut 35:377–381PubMedGoogle Scholar
  64. 64.
    Berk T, Cohen Z, McLeod RS et al (1992) Management of mesenteric desmoid tumors in familial adenomatous polyposis. Can J Surg 35:393–395PubMedGoogle Scholar
  65. 65.
    Bertario L, Russo A, Sala P et al (2001) Genotype and phenotype factors as determinants of desmoid tumors in patients with familial adenomatous polyposis. Int J Cancer 95:102–107PubMedCrossRefGoogle Scholar
  66. 66.
    Clark SK, Neale KF, Landgrebe JC et al (1999) Desmoid tumours complicating familial adenomatous polyposis. Br J Surg 86:1185–1189PubMedCrossRefGoogle Scholar
  67. 67.
    Knudsen AL, Bülow S (2001) Desmoid tumour in familial adenomatous polyposis: a review of literature. Fam Cancer 1:111–119PubMedCrossRefGoogle Scholar
  68. 68.
    Lamlum H, Ilyas M, Rowan A et al (1999) The type of somatic mutation at APC in familial adenomatous polyposis is determined by the site of the germline mutation: a new facet to Knudson’s ‘two-hit’ hypothesis. Nat Med 5:1071–1075PubMedCrossRefGoogle Scholar
  69. 69.
    Palmirotta R, Curia MC, Esposito DL (1995) Novel mutations and inactivation of both alleles of the APC gene in desmoid tumours. Hum Mol Genet 4:1979–1981PubMedCrossRefGoogle Scholar
  70. 70.
    Clark SK, Johnson Smith TGP, Katz DE et al (1998) Identification and progression of a desmoid precursor lesion in patients with familial adenomatous polyposis. Br Jr Surg 85:970–973CrossRefGoogle Scholar
  71. 71.
    Rodriguez-Bigas MA, Mahoney MC, Karakousis CP et al (1994) Desmoid tumors in patients with familial adenomatous polyposis. Cancer 74:1270–1274PubMedCrossRefGoogle Scholar
  72. 72.
    Soravia C, Berk T, McLeod RS et al (2000) Desmoid disease in patients with familial adenomatous polyposis. Dis Colon Rectum 43:363–369PubMedCrossRefGoogle Scholar
  73. 73.
    Penna C, Tiret E, Parc R et al (1993) Operation and abdominal desmoid tumours in familial adenomatous polyposis. Surg Gynecol Obstet 177:263–268PubMedGoogle Scholar
  74. 74.
    Sagar PM, Möslein G, Dozois RR et al (1998) Management of desmoid tumours in patients after ileal pouchanal anastomosis for familial adenomatous polyposis. Dis Colon Rectum 41:1350–1356PubMedCrossRefGoogle Scholar
  75. 75.
    Lynch HT, Fitzgibbons R Jr, Chong S et al (1994) Use of doxorubicin and dacarbazine for the management of unresectable intraabdominal desmoid tumors in Gardner’s syndrome. Dis Colon Rectum 37:260–267PubMedCrossRefGoogle Scholar
  76. 76.
    Soule EH, Scanlon PW (1962) Fibrosarcoma arising in an extra-abdominal desmoid. Mayo Clin Proc 37:433–451Google Scholar
  77. 77.
    Häyry P, Reitamo JJ, Totterman S et al (1982) The desmoid tumour. 2. Analysis of factors possibly contributing to the etiology and growth behavior. Am J Clin Pathol 77:674–680PubMedGoogle Scholar
  78. 78.
    Reitamo JJ (1983) The desmoid tumour. 4. Choice of treatment, results and complications. Arch Surg 118:1318–1322PubMedGoogle Scholar
  79. 79.
    Porru D, Stancati S, Giliberto GL et al (2004) Bilateral ureteral compression by multiple abdominal desmoid tumors in Gardner syndrome: case report and literature review. Urology 64:1031PubMedCrossRefGoogle Scholar
  80. 80.
    Maldjian C, Mitty H, Garten A et al (1995) Abscess formation in a desmoid tumor of Gardner’s syndrome and percutaneous drainage: a report of three cases. Cardiovasc Intervent Radiol 18:168–171PubMedCrossRefGoogle Scholar
  81. 81.
    Richard III HM, Thall EH, Mitty H et al (1997) Desmoid tumor-ureteral fistula in Gardner’s syndrome. Urology 49:135–138PubMedCrossRefGoogle Scholar
  82. 82.
    Church JM (1998) Mucosal ischaemia caused by desmoid tumors in patients with familial adenomatous polyposis. Dis Colon Rectum 41:661–663PubMedCrossRefGoogle Scholar
  83. 83.
    Firoozmand E, Parger E (2001) Pelvic desmoid tumor: threat to mother and fetus. Am Surg 67:1213–1215PubMedGoogle Scholar
  84. 84.
    Clark SK, Phillip RK (1996) Desmoids in familial adenomatous polyposis. Br J Surg 83:1494–1504PubMedGoogle Scholar
  85. 85.
    Anthony T, Rodriguez-Bigas MA, Webwe TK et al (1996) Desmoid tumor. J Am Coll Surg 182:369–377PubMedGoogle Scholar
  86. 86.
    Serpell JW, Paddle-Ledinek JE, Johnson WR (1966) Modification of growth of desmoid tumours in tissue culture by antiestrogenic substances: a preliminary report. Aust N Z J Surg 66:457–463Google Scholar
  87. 87.
    Avisse C, Elbaz M, Pluot M et al (1997) Desmoid tumor of the abdominal wall: report of seven cases. Hernia 1:163–167CrossRefGoogle Scholar
  88. 88.
    Hartley JE, Church JM, Gupta S et al (2004) Significance of incidental desmoids identified during surgery for familial adenomatous polyposis. Dis Colon Rectum 47:334–340PubMedCrossRefGoogle Scholar
  89. 89.
    Brooks AP, Reznek RH, Nugent K et al (1994) CT appearances of desmoid tumors in familial adenomatous polyposis: further observations. Clin Radiol 49:601–607PubMedCrossRefGoogle Scholar
  90. 90.
    Vandevenne JE, De Schepper AM, De Beuckeleer et al (1997) New concepts in understanding evolution of desmoid tumoures: MR imaging of 30 lesions. Eur Radiol 7:1013–1019PubMedCrossRefGoogle Scholar
  91. 91.
    Tonelli F, Valanzano R, Brandi ML (1994) Pharmacologic treatment of desmoid tumours in familial adenomatous polyposis: results of an in vitro study. Surgery 115:473–479PubMedGoogle Scholar
  92. 92.
    Waddell WR, Kirsch WM (1991) Testolactone, sulindac, warfarin and vitamin K1 for unresectable desmoid tumours. Am J Surg 161:416–421PubMedCrossRefGoogle Scholar
  93. 93.
    Tsukada K, Church JM, Jagelman DG, et al (1992) Noncytotoxic drug therapy for intraabdominal desmoid tumor in patients with familial adenomatous polyposis. Dis Colon Rectum 35:29–33PubMedCrossRefGoogle Scholar
  94. 94.
    Samuels BL (1999) Management of recurrent desmoid tumor after surgery and radiation: role of cytotoxic and non-cytotoxic therapies. Surg Oncol 8:191–196PubMedCrossRefGoogle Scholar
  95. 95.
    Tulchinsky H, Keidar A, Strul H et al (2005) Extracolonic manifestations of familial adenomatous polyposis after proctocolectomy. Arch Surg 140:159–164PubMedCrossRefGoogle Scholar
  96. 96.
    Klein WA, Miller HH, Anderson M et al (1987) The use of indomethacin, sulindac and tamoxifen for the treatment of desmoid tumors associated with familial polyposis. Cancer 60:2863–2868PubMedCrossRefGoogle Scholar
  97. 97.
    Lim CL, Walker MJ, Mehta RR et al (1986) Estrogen and antiestrogen binding sites in desmoid tumors. Eur J Cancer Clin Oncol 22:583–587PubMedCrossRefGoogle Scholar
  98. 98.
    Hamilton L, Blackstein M, Berk T et al (1996) Chemotherapy for desmoid tumors in association with familial adenomatous polyposis: a report of three cases. Can J Surg 39:247–252PubMedGoogle Scholar
  99. 99.
    Schnitzler M, Cohen Z, Blackstein M et al (1997) Chemotherapy for desmoid tumors in association with familial adenomatous polyposis. Dis Colon Rectum 40:798–801PubMedCrossRefGoogle Scholar
  100. 100.
    Tsukada K, Church JM, Jagelman DG et al (1991) Systemic cytotoxic chemotherapy for desmoid in familial adenomatous polyposis. Dis Colon Rectum 34:1090–1092PubMedCrossRefGoogle Scholar
  101. 101.
    Kitamura A, Kanagawa T, Yamada S et al (1991) Effective chemotherapy for abdominal desmoid tumour in a patient with Gardner’s syndrome. Dis Colon Rectum 34:822–826PubMedCrossRefGoogle Scholar
  102. 102.
    Middleton SB, Phillips RKS (2000) Surgery for large intra-abdominal desmoid tumours. Dis Colon Rectum 43:1759–1763PubMedCrossRefGoogle Scholar
  103. 103.
    Okuno SH, Edmonson JH (2003) Combination chemotherapy for desmoid tumors. Cancer 97:1134–1135PubMedCrossRefGoogle Scholar
  104. 104.
    Poritz LS, Blackstein M, Berk T et al (2001) Extended follow-up of patients treated with cytotoxic chemotherapy for intra-abdominal desmoid tumors. Dis Colon Rectum 44:1268–1273PubMedCrossRefGoogle Scholar
  105. 105.
    Oohata Y, Mibu R, Uehara S et al (1997) Regression of an abdominal desmoid tumour in a patient with familial adenomatous polyposis by hyperthermoradiotherapy. Am J Gastroenterol 92:156–158PubMedGoogle Scholar
  106. 106.
    Nakada I, Ubukata H, Goto Y et al (1997) Prednisolone therapy for intraabdominal desmoid tumours in a patient with familial adenomatous polyposis. Gastroenterol 32:255–259CrossRefGoogle Scholar
  107. 107.
    Geurs F, Kok TC (1993) Regression of a great abdominal desmoid tumor by interferon-alpha. J Clin Gastroenterol 16:264–265PubMedCrossRefGoogle Scholar
  108. 108.
    Umemoto S, Makuuchi H, Amemiya T et al (1991) Intra-abdominal desmoid tumours in familial polyposis coli: a case report of tumour regression by prednisolone therapy. Dis Colon Rectum 34:89–93PubMedCrossRefGoogle Scholar
  109. 109.
    Wilcken N, Tattersall MH (1991) Endocrine therapy for desmoid tumors. Cancer 68:1384–1388PubMedCrossRefGoogle Scholar
  110. 110.
    Lindor NM, Dozois R, Nelson H et al (2003) Desmoid tumors in familial adenomatous polyposis: a pilot project evaluating efficacy of treatment with pirfenidone. Am J Gastroenterol 98:1868–1874PubMedCrossRefGoogle Scholar
  111. 111.
    Mace J, Sybil Biermann J, Sondak V et al (2002) Response of extraabdominal desmoid tumors to therapy with imatinib mesylate. Cancer 95:2373–2379PubMedCrossRefGoogle Scholar
  112. 112.
    Lev-Chelouche D, Abu-Abeid S, Nakache R et al (1999) Limb desmoid tumours: a possible role for isolated limb perfusion with tumour necrosis factor-alpha ang melphalan. Surgery 126:963–967PubMedCrossRefGoogle Scholar
  113. 113.
    Rock MG, Pritchard DJ, Reiman HM et al (1984) Extraabdominal desmoid tumors. J Bone Joint Surg Am 66:1369–1374PubMedGoogle Scholar
  114. 114.
    Chatzipetrou MA, Tzakis AG, Pinna AD et al (2001) Intestinal transplantation for the treatment of desmoid tumors associated with familial adenomatous polyposis. Surgery 129:277–281PubMedCrossRefGoogle Scholar
  115. 115.
    Tryphonopoulos P, Weppler D, Levi DM et al (2005) Transplantation for the treatment of intra-abdominal fibromatosis. Transplant Proc 37:1379–1380PubMedCrossRefGoogle Scholar
  116. 116.
    Church J, Berk T, Boman BM et al (2005) Collaborative Group of the Americas on Inherited Colorectal Cancer. Staging intra-abdominal desmoid tumors in familial adenomatous polyposis: a search for a uniform approach to a troubling disease. Dis Colon Rectum 48:1528–1534PubMedCrossRefGoogle Scholar
  117. 117.
    Kono T, Tomita I, Chisato N et al (2004) Successful low-dose chemotherapy using vinblastine and methotrexate for the treatment of an ileoanal pouch mesenteric desmoid tumor: report of a case. Dis Colon Rectum 47:246–249PubMedCrossRefGoogle Scholar
  118. 118.
    Sagar PM, Moslein G, Dozois RR (1998) Management of desmoid tumors in patients after ileal pouch-anal anastomosis for familial adenomatous polyposis. Dis Colon Rectum 41:1350–1356PubMedCrossRefGoogle Scholar
  119. 119.
    Guy RJ, Mortensen NJ (2000) Successful resection of an ileoanal pouch mesenteric desmoid without pouch sacrifice: report of a case. Dis Colon Rectum 43:713–716PubMedCrossRefGoogle Scholar
  120. 120.
    Bertario L, Presciuttini S, Sala P et al (1994) Causes of death and postsurgical survival in familial adenomatous polyposis: results from the Italian Registry of Familial Adenomatous Polyposis Writing Committee. Semin Surg Oncol 10:225–234PubMedCrossRefGoogle Scholar
  121. 121.
    Belchetz LA, Berk T, Bapat BV et al (1996) Changing causes of mortality in patients with familial adenomatous polyposis. Dis Colon Rectum 39:384–387PubMedCrossRefGoogle Scholar
  122. 122.
    Brueckl WM, Preuss JM, Wein A et al (2001) Ki-67 expression and residual tumour (R) classification are associated with disease-free survival in desmoid tumour patients. Anticancer Res 21:3615–3620PubMedGoogle Scholar
  123. 123.
    Gardner EJ, Plenk HP (1952) Hereditary pattern for multiple osteomas in a family group. Am J Hum Genet 4:31–36PubMedGoogle Scholar
  124. 124.
    Bilkay U, Edram O, Ozek C et al (2004) Benign osteoma with Gardner syndrome: review of the literature and report of a case. J Craniofac Surg 15:506–509PubMedCrossRefGoogle Scholar
  125. 125.
    Takeuchi T, Takenoshita Y, Kubo K et al (1993) Natural course of jaw lesions in patients with familial adenomatosis coli (Gardner’s syndrome). Int J Oral Maxillofac Surg 22:226–230PubMedCrossRefGoogle Scholar
  126. 126.
    Giardiello FM, Offerhaus GJ, Tarboulsi EI et al (1991) Value of combined phenotypic markers in identifying inheritance of familial adenomatous polyposis. Gut 32:1170–1174PubMedGoogle Scholar
  127. 127.
    Offerhaus GJ, Levin LS, Giardiello FM et al (1987) Occult radiopaque jaw lesions in familial adenomatous polyposis coli and hereditary nonpolyposis colorectal cancer. Gastroenterology 93:490–497PubMedGoogle Scholar
  128. 128.
    Carl W, Herrera L (1987) Dental and bone abnormalities in patients with familial polyposis coli. Semin Surg Oncol 3:77–83PubMedCrossRefGoogle Scholar
  129. 129.
    Ascari-Raccagni A, Baldari U, Righini MG (1999) Cutaneous symptoms of Gardner’s syndrome. J Eur Acad Dermatol Venereol 12:80–81PubMedCrossRefGoogle Scholar
  130. 130.
    Hood AB, Krush AJ (1983) Clinical and dermatologic aspects of the hereditary intestinal polyposes. Dis Colon Rectum 26:546–548PubMedCrossRefGoogle Scholar
  131. 131.
    Marshall KA, Kuhlmann TP, Horowitz JH, et al (1985) Excision of multiple epidermal facial cysts in Gardner’s syndrome. Am J Surg 150:615–616PubMedCrossRefGoogle Scholar
  132. 132.
    Pujol RM, Casanova JM, Egido R, et al (1995) Multiple familial pilomatricomas: a cutaneous marker for Gardner syndrome? Pediatr Dermatol 12:331–335PubMedGoogle Scholar
  133. 133.
    Traboulsi EI (2005) Ocular manifestations of familial adenomatous polyposis (Gardner syndrome). Ophthalmol Clin North Am 18:163–166PubMedCrossRefGoogle Scholar
  134. 134.
    Shields JA, Shields CL, Shah PG et al (1992) Lack of association among typical congenital hypertrophy of the retinal pigment epithelium, adenomatous polyposis, and Gardner syndrome. Ophthalmology 99:1709–1713PubMedGoogle Scholar
  135. 135.
    Kasner L, Traboulsi EI, Delacruz Z et al (1992) A histopathologic study of the pigmented fundus lesions in familial adenomatous polyposis. Retina 12:35–42PubMedCrossRefGoogle Scholar
  136. 136.
    Traboulsi EI, Krush AJ, Gardner EJ et al (1987) Prevalence and importance of pigmented ocular fundus lesions in Gardner’s syndrome. N Engl J Med 316:661–667PubMedCrossRefGoogle Scholar
  137. 137.
    Olschwang S, Tiret A, Laurent-Puig P et al (1993) Restriction of ocular fundus lesions to a specific subgroup of APC mutations in adenomatous polyposis coli patients. Cell 75:959–968PubMedCrossRefGoogle Scholar
  138. 138.
    Cetta F, Montalto G, Gori M et al (2000) Germline mutations of the APC gene in patients with familial adenomatous polyposis-associated thyroid carcinoma: results from a European cooperative study. J Clin Endocrinol Metab 85:286–292PubMedCrossRefGoogle Scholar
  139. 139.
    Giardiello FM, Offerhaus GJ, Lee DH et al (1993) Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis. Gut 34:1394–1396PubMedGoogle Scholar
  140. 140.
    Plail RO, Bussey HJ, Glazer G et al (1987) Adenomatous polyposis: an association with carcinoma of the thyroid. Br J Surg 74:377–380PubMedGoogle Scholar
  141. 141.
    Herrera L, Carrel A, Rao U et al (1989) Familial adenomatous polyposis in association with thyroiditis: report of two cases. Dis Colon Rectum 32:893–896PubMedCrossRefGoogle Scholar
  142. 142.
    Turcot J, Despres JP, St Pierre F (1959) Malignant tumors of the central nervous system associated with familial polyposis of the colon: report of two cases. Dis Colon Rectum 2:465–468PubMedGoogle Scholar
  143. 143.
    Paraf F, Jothy S, Van Meir EG (1997) Brain tumorpolyposis syndrome: two genetic diseases? J Clin Oncol 15:2744–2758PubMedGoogle Scholar
  144. 144.
    Gadish T, Tulchinsky H, Deutsch AA et al (2005) Pinealoblastoma in a patient with familial adenomatous polyposis: variant of Turcot syndrome type 2? Report of a case and review of the literature. Dis Colon Rectum 48:2343–2346PubMedCrossRefGoogle Scholar
  145. 145.
    Jagelman DG, DeCosse JJ, Bussey HJ (1988) Upper gastrointestinal cancer in familial adenomatous polyposis. Lancet 1:1149–1151PubMedCrossRefGoogle Scholar
  146. 146.
    Walsh N, Qizilbash A, Banerjee R et al (1987) Biliary neoplasia in Gardner’s syndrome. Arch Pathol Lab Med 111:76–77PubMedGoogle Scholar
  147. 147.
    Bernstein IT, Bulow S, Mauritzen K (1992) Hepatoblastoma in two cousins in a family with adenomatous polyposis: report of two cases. Dis Colon Rectum 35(4):373–374PubMedCrossRefGoogle Scholar
  148. 148.
    Hughes LJ, Michels VV (1992) Risk of hepatoblastoma in familial adenomatous polyposis. Am J Med Genet 43:1023–1025PubMedCrossRefGoogle Scholar
  149. 149.
    Painter TA, Jagelman DG (1985) Adrenal adenomas and adrenal carcinomas in association with hereditary adenomatosis of the colon and rectum. Cancer 55:2001–2004PubMedCrossRefGoogle Scholar
  150. 150.
    Marchesa P, Fazio VW, Church JM et al (1997) Adrenal masses in patients with familial adenomatous polyposis. Dis Colon Rectum 40(9):1023–1028PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2006

Authors and Affiliations

  • Yehuda Kariv
    • 1
  • Hagit Tulchinsky
    • 1
  • Micha Rabau
    • 1
  1. 1.Unit of Colon and Rectal Surgery Department of Surgery BTel Aviv Sourasky Medical CenterTel AvivIsrael

Personalised recommendations